1 year return (CAGR)
-95.56%
Altamira Therapeutics Ltd Exchange (NASDAQ, USD)
CYTO
-
-0.28 (-69.67%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-93.89%
5 year return (CAGR)
-81.68%
10 year return (CAGR)
-77.00%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
452.67K
Price/Sales
8.58
Ent value
1.07M
Price/Book
0.07
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-69.69%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.14 |
| Daily high | 0.20 |
| Daily low | 0.10 |
| Daily Volume | 745K |
| 1y analyst estimate | 4.93 |
| Beta | 2.44 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CYTO | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.74% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -85.93% | -10.68% |
| Avg time to new high | 326 days | 12 days |
| Max time to new high | 2255 days | 1805 days |
News
No items found